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Purpose: Acute pyelonephritis (APN) is a serious bacterial infection that can cause renal scarring 
in children. Early identification of APN is critical to improve treatment outcomes. The neutrophil-
lymphocyte ratio (NLR) is a prognostic marker of many diseases, but it has not yet been established in 
urinary tract infection (UTI). The aim of this study was to determine whether NLR is a useful marker to 
predict APN or vesicoureteral reflux (VUR).
Methods: We retrospectively evaluated 298 pediatric patients (age≤36 months) with febrile UTI from 
January 2010 to December 2014. Conventional infection markers (white blood cell [WBC] count, 
erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]), and NLR were measured.
Results: WBC, CRP, ESR, and NLR were higher in APN than in lower UTI (P<0.001). Multiple logistic 
regression analyses showed that NLR was a predictive factor for positive dimercaptosuccinic acid 
(DMSA) defects (P<0.001). The area under the receiver operating characteristic (ROC) curve was high 
for NLR (P<0.001) as well as CRP (P<0.001) for prediction of DMSA defects. NLR showed the highest 
area under the ROC curve for diagnosis of VUR (P<0.001).
Conclusion: NLR can be used as a diagnostic marker of APN with DMSA defect, showing better results 
than those of conventional markers for VUR prediction.
Key words: Urinary tract infections, Pyelonephritis, Vesico-ureteral reflux, Child, Neutrophil-lympho-
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Introduction
An acute urinary tract infection (UTI) is a common bacterial infection that causes an 
inflammatory response and may lead to serious morbidity in infants and children1). 
Approximately 1% of boys and 3–5% of girls have at least one UTI during childhood, and 
30–50% of these children will have at least one recurrence2). It may be not easy to reco­
gnize UTI in infants and children, particularly those younger than 3 years, because the 
presenting symptoms and signs are nonspecific1). 
UTI often occurs as a simple bladder infection, but can also involve the kidneys, which is 
termed an acute pyelonephritis (APN). APN is an infection of the renal parenchyma, which 
can lead to renal scar formation and increased risk of hypertension, chronic kidney disease 
(CKD), and ultimately end­stage renal disease (ESRD)3,4). Consequently, prompt differential 
diagnosis of APN and timely initiation of the appropriate antibiotics are the important keys 
to the management of UTIs. 
There are several studies examining potential accurate, noninvasive biomarkers for the 
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ability to discriminate APN in children5­8). Several parameters of 
the systemic inflammatory response, including level of white 
blood cell (WBC) count, procalcitonin (PCT), c­reactive protein 
(CRP), and erythrocyte sedimentation rate (ESR), were not accurate 
enough to confidently differentiate8,9). However, there have been 
several studies showing that neutrophil­lymphocyte ratio (NLR) is 
a measure of systemic bacterial inflammation and it has been used 
as a guide to prognosis in community­acquired pneumo nia, is­
chemic heart disease, and several types of cancer10). Thus, NLR 
may serve as a useful diagnostic indicator and prognostic factor of 
APN, but there are no studies on the usefulness of NLR in children 
with UTIs.
NLR of the patients admitted is easily calculated and immedi­
ately available based on a complete blood count. In the present 
study, we aim ed to validate the value of NLR that can be used as 
a substantial inflammatory marker of APN and predictive marker 
of compli cations in young children with febrile UTI.
Materials and methods
1. Patients and inclusion criteria
Data from 298 pediatric patients less than 36 months of age 
with febrile UTI admitted to Severance Children’s Hospital from 
January 2010 to December 2014 were retrospectively analyzed. 
The diagnosis of a first­time febrile UTI for entry into this study 
was based on the following criteria: (1) a fever of ≥38°C, (2) a 
pyuria (≥5 WBCs per high­power field), (3) a positive urine culture 
collected from a clean­catch or catheterized specimen (defined as 
growth of a single organism to ≥100,000 colony­forming units/
mL), (4) no previous history of UTI, kidney or bladder disease. 
Imaging studies, including renal ultrasonography (USG), dimer­
captosuccinic acid (DMSA) scan and voiding cystourethrogram 
(VCUG), were performed.
Patients were divided into two groups according to the pre­
sence of defects as determined by DMSA scans. VUR was defined 
as the retrograde passage of urine from the bladder into ureters or 
kid ney by VCUG study11,12). The VCUG was performed after end of 
the antibiotics treatment.
2. Data analysis
Clinical data, such as age, sex, and duration of fever were re­
corded. Before initiation of antibiotic treatment, blood was sampl­
ed for laboratory analyses, including a complete blood cell count 
(CBC), WBC, neutrophils, lymphocytes, ESR, CRP. The NLR was 
then calculated using neutrophils/lymphocytes. 
Peripheral venous blood samples were collected by antecubital 
venipuncture into vacutainer tubes (Becton Dickinson, Ruther­
ford, NJ, USA) containing tripotassium ethylenediaminete­
traacetic acid. CBCs were done within 1 hour after the blood sam­
ples were drawn. CBC analysis was performed using the Advia 
2120i automated analyzer (Siemens Healthcare Diagnostics, 
Deerfield, IL, USA). CRP levels were measured by the latex­en­
hanced turbidimetric assay method using a Hitachi 7600 P 
module (Hitachi, Tokyo, Japan). ESR levels were measured by the 
TEST 1 (Alifax, Padova, Italy). Strict quality control procedures 
were adopted.
Imaging studies including USG, DMSA, and VCUG were per­
formed in febrile patients with UTI. After the patients were admit­
ted due to UTI, USG and DMSA scan were performed within the 
first 5 days. VCUG was done within 4 weeks after two­week anti­
biotics therapy. 
Urine collection was obtained with sterile and sealed urine col­
lection bags or clean urethral catheters for febrile infants. These 
urinary examinations were done upon admission to the hospital 
before any administration of fluid therapies or antibiotics intra­
venously.
3. Statistical methods
IBM SPSS ver. 18.0 (IBM Co., Armonk, NY, USA) was used to 
compare variables. Independent t test was used for continuous 
variables with normal distribution, in addition to descriptive 
statistics expressed as mean±standard deviation. Chi­square test 
was used to analyze categorical variables. Correlation analysis 
was carried out to determine the relationship between two vari­
ables by Spearman correlation. The discriminative ability of each 
bio marker for APN was evaluated by plotting receiver operating 
characteristic (ROC) curves for the biomarkers. Multiple logistic 
regression analyses were performed to find independent predic­
tive factors for positive DMSA defects and present VUR in UTI 
patients. All differences were considered significant at a value of 
P<0.05. 
4. Ethics statement 
The institutional review board (IRB) and Research Ethics Com­
mittee of Yonsei University Severance Hospital approved this 
study. The IRB exempted informed consents because of the nature 
of retrospective study. Personal identifiers were completely re­
moved and the data were analyzed anonymously. Our study was 
conducted according to the ethical standards laid down in the 
1964 Declaration of Helsinki and its later amendments.
Results
The clinical characteristics and laboratory findings of the pa­
tients are showed in Table 1. Among the 298 children with a first 
episode of a febrile UTI, 163 tested positive for a DMSA defect 
(116 males and 47 females), and 135 did not show a DMSA defect 
(98 males and 37 females) (P=0.785). There were no differences 
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regarding the age between of the groups (P=0.149). The WBC, 
NLR, ESR, and CRP levels were compared between these two 
groups. For all measurements (WBC, NLR, ESR, and CRP), values 
were significantly higher in the group of APN with DMSA defect 
(P< 0.001), suggesting that these values may help us distinguish 
DMSA defect of APN in children.
Next, renal USG results were compared between positive 
DMSA defect and negative DMSA defect groups. Abnormal USG 
results correlated significantly with renal cortical defect and they 
were detected in 76.1% of the APN patients (P=0.004). There was 
a significant difference in the incidence of VUR among children 
with and without renal lesions. Among 84 VUR patients, 70 (42.9 
%) were found to have VUR in positive renal scans, but only 14 
(10.4%) had VUR in negative renal scans (P<0.001) (Table 1).
Renal USG abnormalities were divided into 5 groups. The most 
common finding was pelvic dilation, which was seen in 78 
patients. Among those patients, DMSA defect (P=0.086) was seen 
in 36. The second common finding was hydronephrosis (57 
patients), and 42 patients of them were showed a significant 
defect on DMSA scan (P=0.002). Dilatation of the ureter was seen 
in 31 patients, and increased focal vascularity of the kidney 
cortex was seen in 30 of those patients, which means a presence 
focal APN. We could not find any significant association with 
DMSA defect (P=1.000 and P=0.034). The group of others was 2 
patients with polycystic kidney disease and 1 patient with a 
horseshoe kidney (Table 2). 
We divided our patients according to the VUR grading system 
of the International Reflux Study12) and grouped them to mild 
(grades 1–2) and severe (grades 3–5). In cases with bilateral VUR, 
grading was done by the more severe side. We analyzed mild and 
severe VUR groups according to the renal USG findings (Table 3). 
The renal USG findings included normal, pelvic dilatation, hydro­
nephrosis, ureter dilatation, increased focal vascularities, and the 
others. There was significant difference between mild and severe 
VUR only in normal USG group (P=0.004). 
We checked if there was any relationship of NLR and CRP 
between the groups of VUR grades. Upon an independent sample 
test, NLR and CRP both have shown no significant association 
with VUR grades (P=0.616 and P=0.081).
Multiple logistic regression analyses were performed to test 
each parameter as an independent predictor of positive DMSA 
scans. These results showed that CRP (odds ratio [OR], 1.022; 95% 
confidence interval [CI], 1.013–1.030; P<0.001) and NLR (OR, 
1.603; 95% CI, 1.263–2.035; P<0.001) were independent predic­
tive factors for positive DMSA defects in UTI patients (Table 4).
The diagnostic properties of the various inflammatory markers 
were examined for their predictability of a defect as detected by a 
DMSA scan using ROC curves. The median area under the ROC 
curve was 0.660 for WBC (95% CI, 0.598–0.723; P<0.001), 0.713 
for NLR (95 % CI, 0.654–0.771; P<0.001), 0.611 for ESR (95% CI, 
0.547–0.675; P<0.001), and 0.726 for CRP (95% CI, 0.669–0.783; 
P<0.001) (Table 5, Fig. 1). These results suggest that CRP is the 
Table 1. Comparison of variables between patients with and without 
renal cortical defects detected by DMSA scans
Variable DMSA defect (+) (n=163)
DMSA defect (–) 
(n=135) P value
Age (mo) 4.3±4.0 4.9±3.1 0.149
Sex 0.785
Male:female 116:47 98:37
WBC (/mm3) 17,285±6,341 14,026±5,338 <0.001
NLR 2.5±2.3 1.4±1.0 <0.001
ESR (mm/hr) 44.8±31.6 32.4±24.3 <0.001
CRP (mg/L) 71.7±68.6 31.5±26.8 <0.001
USG abnormality 124 (76.1) 82 (60.7) 0.004
VUR   70 (42.9) 14 (10.4) <0.001
Values are presented as mean±standard deviation or number (%).
DMSA, dimercaptosuccinic acid; WBC, white blood cell; NLR, neutrophil 
lymphocyte ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 
USG, ultrasonography; VUR, vesicoureteral reflux.
Table 2. Renal ultrasonography abnormalities according to the renal 
cortical defects detected by DMSA scans
Variable DMSA defect (+) (n=163)
DMSA defect (–) 
(n=135) P value
Normal 44 (27.0) 55 (40.7) 0.014
Pelvic dilatation 36 (22.1) 42 (31.1) 0.086
Hydronephrosis 42 (25.8) 15 (11.1) 0.002
Ureter dilatation 17 (10.4) 14 (10.4) 1.000
Increased focal vascularities 22 (13.5) 8 (5.9) 0.034
Others
PKD 1 (0.6) 0 (0) 1.000
Horseshoe kidney 1 (0.6) 1 (0.7) 1.000
Values are presented as number (%).
DMSA, dimercaptosuccinic acid; PKD, polycystic kidney disease. 
Table 3. Renal ultrasonography abnormalities according to the VUR 
grade
Variable Mild VUR (n=214)
Severe VUR 
(n=84) P value
Normal 82 (38.3) 17 (20.2) 0.004
Pelvic dilatation 58 (27.1) 20 (23.8) 0.661
Hydronephrosis 33 (15.4) 24 (28.6) 0.014
Ureter dilatation 18 (8.4) 13 (15.5) 0.091
Increased focal vascularities 23 (10.7) 7 (8.3) 0.670
Others
PKD 0 (0) 1 (1.2) 0.282
Horseshoe kidney 0 (0) 2 (2.4) 0.079
Values are presented as number (%).
VUR grade: mild, 1–2; severe, 3–5.
VUR, vesicoureteral reflux; PKD, polycystic kidney disease.
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most predictable value of a DMSA defect and NLR is also a good 
predictor equally to CRP. 
Finally, the diagnostic properties of the various inflammatory 
markers were examined for their predictability of VUR (Table 6, 
Fig. 2). The median area under the ROC curve was 0.570 for WBC 
(95% CI, 0.496–0.643; P=0.061), 0.638 for NLR (95% CI, 0.565–
0.711; P<0.001), 0.419 for ESR (95% CI, 0.344–0.494; P=0.03), 
and 0.533 for CRP (95% CI, 0.459–0.607; P=0.374). These results 
indicate that NLR is the most predictable value of the presence of 
VUR than others.
Discussion
UTI is a common bacterial infection in childhood1). Most pedi­
atric hospitals have therapeutic experience with this disease. In 
some children with UTI, the infection is localized to the bladder, 
while bacteria ascend to the kidney (APN) in others5). Only child­
ren with upper UTI are at risk for developing renal scarring, which 
affects the long­term prognosis of kidney diseases such as hyper­
tension, CKD, or ESRD3,4). Therefore, prompt detec tion of com­
plications such as renal scarring and VUR is important to the 
management of UTIs in children. 
Currently, two diagnostic methods are in place to detect renal 
parenchymal involvement: DMSA scan and USG13). The DMSA 
scan is a very sensitive detection method and considered as a 
superior tool for assessment of the extent and pro gress of renal 
Table 4. Multiple logistic regression analysis of laboratory parameters 
associated with renal cortical defects detected by dimercaptosuccinic 
acid scans
Variable Odds ratio 95% CI P value
WBC (/mm3) 1.000 1.000–1.000 0.676
Neutrophil (/mm3) 1.012 0.972–1.055 0.556
NLR 1.603 1.263–2.035 <0.001
ESR (mm/hr) 0.998 0.986–1.011 0.807
CRP (mg/L) 1.022 1.013–1.030 <0.001
CI, confidence interval; WBC, white blood cell; NLR, neutrophil-lymphocyte 
ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
Table 5. Receiver operating characteristic analysis of inflammatory 
markers that predict positive dimercaptosuccinic acid scans
Variable Area under curve Standard error P value 95% CI
WBC (/mm3) 0.660 0.032 <0.001 0.598–0.723
NLR 0.713 0.030 <0.001 0.654–0.771
ESR (mm/hr) 0.611 0.033 <0.001 0.547–0.675
CRP (mg/L) 0.726 0.269 <0.001 0.669–0.783
CI, Confidence interval; WBC, white blood cell; NLR, neutrophil-lymphocyte 
ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein. 
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Fig. 1. Receiver operating characteristic curves of C-reactive protein 
(CRP), white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), 
and neutrophil-lymphocyte ratio (NLR) for differentiating between positive 
and negative results from dimercaptosuccinic acid (DMSA) scans. The 
area under curves of NLR and CRP show a significant correlation to 
DMSA scans positive for a defect (P<0.001).
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Fig. 2. Receiver operating characteristic curves of C-reactive protein 
(CRP), white blood cell (WBC) count, erythrocyte sedimentation rate (ESR) 
and neutrophil-lymphocyte ratio (NLR) for the prediction of vesicoureteral 
reflux.
Table 6. Receiver operating characteristic analysis of inflammatory 
markers that predict the presence of vesicoureteral reflux
Variable Area under curve Standard error P value 95% CI
WBC (/mm3) 0.570 0.038 0.061 0.496–0.643
NLR 0.638 0.037 <0.001 0.565–0.711
ESR (mm/hr) 0.419 0.038 0.030 0.344–0.494
CRP (mg/L) 0.533 0.038 0.374 0.459–0.607
CI, Confidence interval; WBC, white blood cell; NLR, neutrophil-lymphocyte 
ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein. 
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scarring over USG11). However, DMSA has se veral limitations, 
including availability in all centers, higher cost, and radiation 
exposure9). Additionally, the test is required sedation process 
during the scanning for young children. 
Because of the limitations described above, many studies have 
been conducted to predict renal complication of APN with 
noninvasive and widely used biomarkers, such as PCT, CRP, ESR, 
and WBC. In this study, high CRP levels correlated with defects 
found on a positive DMSA scan and the presence of VUR. How­
ever, several other studies have shown that these markers could 
not reliably distinguish renaI complications13). In one study, CRP 
was not sufficient as a predictive value, with sensitivity of 83%14). 
In another study, CRP had a sensitivity of 100%, but a specificity 
of 18.5%15). Such results are not adequate to meet expectations. In 
one comprehensive review in 2015, Shaikh et al.9) examined the 
usefulness of PCT, CRP, and ESR for the renal scarring in UTI with 
24 relevant studies, of which 17 provided data. They found that 
none of the tests were accurate enough to allow clinicians to 
confidently detect renaI scarring9). 
Our study shows a significant difference in the incidence of 
VUR among children with and without renal lesions (42.9% vs. 
10.4%). According to the systematic overview of 33 studies that 
examined the prognosis in UTI children, approximately 25% of 
children with an initial UTI had VUR, and 57% of them had 
DMSA scan findings consistent with APN16). Children with VUR 
were significantly more likely to develop APN and renal scarring 
compared to children without VUR16). Although we suggest that 
the identification of VUR is important, a VCUG is not recom­
mended in the first UTI event. A VCUG is indicated only that if 
USG reveals hydronephrosis or renal scarring that could suggest 
either VUR or obstructive uropathy17). The VCUG procedure poses 
a significant burden to patients and physicians due to its invasive 
nature and risk of radiation exposure.
The aim of this study was to present the NLR as a practical 
biomarker that could predict APN. It is clear that there are im­
portant association between the NLR and bacterial infection such 
as pneumonia, sepsis, and systemic inflammatory response18­20). 
In this setting, increased NLR outperformed conventional mark­
ers, such as WBC, neutrophil counts, and CRP, as a useful biomar­
ker to detect bacteremia10,19,20). WBC differential counts undergo a 
number of rapid, serial changes in response to surgical stress, 
systemic inflammation, or sepsis21). Characteristically, total WBCs 
and neutrophils increase and lymphocytes decrease, parti cularly 
in a bacterial infection by the classic cellular shift22). The under­
lying mechanism of neutrophilia is the activity of growth factors 
on stem cells to stimulate neutrophil generation22). The induction 
of the tumor necrosis factor family occurs early in the inflam­
matory response; these receptors are expressed on lympho cytes 
and cause lymphocyte apoptosis. Lymphocytopenia has been 
reported as a diagnostic marker of bacterial infection 19,23). There­
fore, NLR can play a special role as a predictive marker of bac­
terial infection compared to neutrophilia or lymphocyto penia 
alone18).
This study revealed a significant correlation between elevated 
NLR and DMSA defect of APN. The inflammatory markers (WBC, 
ESR, CRP, and NLR) were all investigated, and our study showed 
that CRP had the highest AUC value of 0.726, followed by NLR 
(0.713), WBC (0.660), and ESR (0.611) as determined on the ROC 
curves (P<0.001). On the other hand, NLR was more associative 
than CRP in the multiple logistic regression analysis (OR: 1.603 
vs. 1.022, P<0.001) (Table 2). Furthermore, the highest association 
between NLR and presence of VUR was found using the ROC 
curves to calculate the AUC value of 0.638, which was greater 
than that for WBC (0.570), CRP (0.533), and ESR (0.419) (P<0.001).
In conclusion, this report is the first study that presents the use­
fulness of NLR as a value to predict DMSA defect and VUR in 
young children with febrile UTI. NLR is a simple, cheap, and easy 
parameter of inflammation because it can be measured in almost 
all laboratories. The data from this study suggest that NLR was 
correlated significantly with DMSA defect in pediatric patients 
with UTI. Furthermore, NLR may be a reliable marker for the 
prediction of VUR.
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